-
As a way to indirectly investigate the effects of lubricating products used by infertile women during intercourse on sperm quality, semen from 22 normospermic men was tested against several common lubricants (Pre-Seed®, Astroglide®, K-Y® Sensitive®, K-Y® Warming®, and K-Y® Tingling) and natural oils (baby, canola, sesame, and mustard) at 0, 5, 30 and 60 minutes.
-
A study that has focused on patients who are exposed to second-hand smoke shows a higher rate of preeclampsia than nonsmokers.
-
This randomized, controlled trial demonstrates that women are able to self-administer subcutaneous depot medroxyprogesterone acetate at home correctly and without complication.
-
Almost all of the women who elected to continue use of a levonorgestrel intrauterine system by replacement after the first 5-year interval had favorable bleeding patterns during the second 5 years of use, with almost half experiencing amenorrhea.
-
Good news: More women are choosing long-acting reversible contraceptives (LARC methods) such as the intrauterine device (IUD) and the contraceptive implant.
-
The Centers for Disease Control and Prevention (CDC) has issued new interim guidance for use of pre-exposure prophylaxis (PrEP) for in heterosexual men and women at high risk for HIV.
-
Findings from a just-published study of young women ages 13-16 in Cincinnati are the first to document herd protection after introduction of the human papillomavirus (HPV) vaccine.
-
The North American Menopause Society, the American Society for Reproductive Medicine, and The Endocrine Society have issued a joint statement concluding that hormone therapy (HT) is still an acceptable treatment for menopausal symptoms.
-
Two sister studies have been launched in Africa to evaluate the ability of a new monthly vaginal ring containing the antiretroviral drug dapivirine to safely prevent new HIV infections in women.
-
Update your practice: The Centers for Disease Control and Prevention (CDC) no longer recommends the oral antibiotic cefixime as a first-line treatment option for gonorrhea due to possible drug resistance.
